524 related articles for article (PubMed ID: 32859588)
21. Sex specific molecular networks and key drivers of Alzheimer's disease.
Guo L; Cao J; Hou J; Li Y; Huang M; Zhu L; Zhang L; Lee Y; Duarte ML; Zhou X; Wang M; Liu CC; Martens Y; Chao M; Goate A; Bu G; Haroutunian V; Cai D; Zhang B
Mol Neurodegener; 2023 Jun; 18(1):39. PubMed ID: 37340466
[TBL] [Abstract][Full Text] [Related]
22. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
24. A Friend and a Foe: 50 Years of the Apolipoprotein E Research Trail.
Levy Y; Levy D
Isr Med Assoc J; 2021 Oct; 23(10):665-669. PubMed ID: 34672451
[TBL] [Abstract][Full Text] [Related]
25. Genetic factors associated with the predisposition to late onset Alzheimer's disease.
Durmaz A; Kumral E; Durmaz B; Onay H; Aslan GI; Ozkinay F; Pehlivan S; Orman M; Cogulu O
Gene; 2019 Jul; 707():212-215. PubMed ID: 31102717
[TBL] [Abstract][Full Text] [Related]
26. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
27.
Yang A; Kantor B; Chiba-Falek O
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513969
[TBL] [Abstract][Full Text] [Related]
28. Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders.
Schmechel DE; Browndyke J; Ghio A
Neurotoxicology; 2006 Sep; 27(5):637-57. PubMed ID: 16870258
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
[TBL] [Abstract][Full Text] [Related]
30. Age-Dependent Changes to Sphingolipid Balance in the Human Hippocampus are Gender-Specific and May Sensitize to Neurodegeneration.
Couttas TA; Kain N; Tran C; Chatterton Z; Kwok JB; Don AS
J Alzheimers Dis; 2018; 63(2):503-514. PubMed ID: 29660940
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
Kamboh MI
Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
[TBL] [Abstract][Full Text] [Related]
32. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease.
Buttini M; Akeefe H; Lin C; Mahley RW; Pitas RE; Wyss-Coray T; Mucke L
Neuroscience; 2000; 97(2):207-10. PubMed ID: 10799751
[TBL] [Abstract][Full Text] [Related]
33. Age, APOE and sex: Triad of risk of Alzheimer's disease.
Riedel BC; Thompson PM; Brinton RD
J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
[TBL] [Abstract][Full Text] [Related]
34. Impact of the apolipoprotein E polymorphism, age and sex on neurogenesis in mice: pathophysiological relevance for Alzheimer's disease?
Koutseff A; Mittelhaeuser C; Essabri K; Auwerx J; Meziane H
Brain Res; 2014 Jan; 1542():32-40. PubMed ID: 24140109
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
[TBL] [Abstract][Full Text] [Related]
36. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Shi Y; Manis M; Long J; Wang K; Sullivan PM; Remolina Serrano J; Hoyle R; Holtzman DM
J Exp Med; 2019 Nov; 216(11):2546-2561. PubMed ID: 31601677
[TBL] [Abstract][Full Text] [Related]
37. Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
Lou T; Tao B; Chen M
Neuroscience; 2023 Mar; 514():123-140. PubMed ID: 36736614
[TBL] [Abstract][Full Text] [Related]
38. A rare variant in MLKL confers susceptibility to ApoE ɛ4-negative Alzheimer's disease in Hong Kong Chinese population.
Wang B; Bao S; Zhang Z; Zhou X; Wang J; Fan Y; Zhang Y; Li Y; Chen L; Jia Y; Li J; Li M; Zheng W; Mu N; Wang L; Yu Z; Wong DSM; Zhang Y; Kwan J; Ka-Fung Mak H; Ambalavanan A; Zhou S; Cai W; Zheng J; Huang S; Rouleau GA; Yang W; Rogaeva E; Ma X; St George-Hyslop P; Chu LW; Song YQ
Neurobiol Aging; 2018 Aug; 68():160.e1-160.e7. PubMed ID: 29656768
[TBL] [Abstract][Full Text] [Related]
39. Neuroimaging and APOE genotype: a systematic qualitative review.
Cherbuin N; Leach LS; Christensen H; Anstey KJ
Dement Geriatr Cogn Disord; 2007; 24(5):348-62. PubMed ID: 17911980
[TBL] [Abstract][Full Text] [Related]
40. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal.
Pedersen WA; Chan SL; Mattson MP
J Neurochem; 2000 Apr; 74(4):1426-33. PubMed ID: 10737598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
